Apellis Pharmaceuticals, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
APLS Company Description
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
APLS Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view APLS Smart Score
Score Breakdown
APLS Company Description
Show More
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of APLS by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by APLS's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on APLS's company Twitter account
WallStreetBets
Number of mentions of APLS in WallStreetBets Daily Discussion
APLS News
Recent insights relating to APLS
CNBC Recommendations
Recent picks made for APLS stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in APLS
Corporate Flights
Flights by private jets registered to APLS
Our Analysis